Fenchem Preparing for Hyamax Clinical

July 24, 2006

1 Min Read
Fenchem Preparing for Hyamax Clinical

NANJING, China—Fenchem Enterprises (www.fenchem.com) is preparing a protocol for clinical tests in animals and humans on the impact of its Hyamax™ sodium hyaluronate (HA) at different molecular weights. According to Fenchem, the study is designed to compare distribution and metabolism of HA with different molecular weights to determine the best weight for maximum absorption and efficiency for joint health. Hyamax is produced through microbial fermentation and is available in molecular weights from 8,000 to 3 million Da (Daltons).

Subscribe and receive the latest insights on the health and nutrition industry.
Join 37,000+ members. Yes, it's completely free.

You May Also Like